Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End Use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Market Size & Trends
The global pharmaceutical analytical testing services in CRO market size was estimated at USD 7.52 billion in 2024 and is projected to grow at a CAGR of 8.61% from 2025 to 2030. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.
In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.
As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.
Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.
Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.
Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.
Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.
SGS Soci?t? G?n?rale de Surveillance SA
Worldwide Clinical Trials
Sofpromed
ClinChoice
Evotec
Eurofins Scientific
KYMOS Group
ViviaBiotech S.L.
GalChimia
TCI Laboratories
Cotecna (NEOTRON SpA,)
Tentamus
Enzymlogic
Pharmbiotest
UNIFARM - Research Centre
ANAPHARM EUROPE, S.L.U
Market Size & Trends
The global pharmaceutical analytical testing services in CRO market size was estimated at USD 7.52 billion in 2024 and is projected to grow at a CAGR of 8.61% from 2025 to 2030. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.
In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.
As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.
Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.
Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.
Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.
Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.
- Service Outlook (Revenue, USD Million, 2018 - 2030)
- Bioanalytical Testing
- Clinical
- Non-Clinical
- Method Development & Validation
- Extractable & Leachable
- Impurity Method
- Technical Consulting
- Others
- Stability Testing
- Drug Substance
- Stability Indicating Method Validation
- Accelerated Stability Testing
- Photostability Testing
- Others
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Poland
- Switzerland
- Austria
- Czech Republic
- Croatia
- Slovenia
- Greece
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Argentina
- UAE
- Kuwait
SGS Soci?t? G?n?rale de Surveillance SA
Worldwide Clinical Trials
Sofpromed
ClinChoice
Evotec
Eurofins Scientific
KYMOS Group
ViviaBiotech S.L.
GalChimia
TCI Laboratories
Cotecna (NEOTRON SpA,)
Tentamus
Enzymlogic
Pharmbiotest
UNIFARM - Research Centre
ANAPHARM EUROPE, S.L.U
CHAPTER 1. RESEARCH METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis
CHAPTER 4. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. SGS Soci?t? G?n?rale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis
CHAPTER 4. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. SGS Soci?t? G?n?rale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
LIST OF TABLES
Table 1 LIST OF TABLES
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 1 LIST OF TABLES
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key Country Dynamics
Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key Country Dynamics
Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key Country Dynamics
Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key Country Dynamics
Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key Country Dynamics
Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key Country Dynamics
Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key Country Dynamics
Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key Country Dynamics
Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key Country Dynamics
Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key Country Dynamics
Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key Country Dynamics
Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key Country Dynamics
Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key Country Dynamics
Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key Country Dynamics
Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key Country Dynamics
Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key Country Dynamics
Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key Country Dynamics
Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key Country Dynamics
Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key Country Dynamics
Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key Country Dynamics
Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key Country Dynamics
Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key Country Dynamics
Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key Country Dynamics
Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key Country Dynamics
Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key Country Dynamics
Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key Country Dynamics
Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key Country Dynamics
Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key Country Dynamics
Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key Country Dynamics
Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key company categorization
Fig. 108 Service heat map analysis
Fig. 109 Strategic framework
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key Country Dynamics
Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key Country Dynamics
Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key Country Dynamics
Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key Country Dynamics
Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key Country Dynamics
Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key Country Dynamics
Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key Country Dynamics
Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key Country Dynamics
Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key Country Dynamics
Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key Country Dynamics
Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key Country Dynamics
Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key Country Dynamics
Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key Country Dynamics
Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key Country Dynamics
Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key Country Dynamics
Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key Country Dynamics
Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key Country Dynamics
Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key Country Dynamics
Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key Country Dynamics
Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key Country Dynamics
Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key Country Dynamics
Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key Country Dynamics
Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key Country Dynamics
Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key Country Dynamics
Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key Country Dynamics
Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key Country Dynamics
Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key Country Dynamics
Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key Country Dynamics
Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key Country Dynamics
Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key company categorization
Fig. 108 Service heat map analysis
Fig. 109 Strategic framework
